Constellation EZH2 inhibitor

long-residence time EZH2 inhibitor

oral efficacy in xenograft model

from optimatization of prior EZH2 inhibitor

"ACS Med. Chem. Lett., Mar. 26, 2020

Constellation Pharma., Cambridge, MA

Constellation EZH2 inhibitor (Constellation oral in vivo long-residence time EZH2 inhibitor)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.